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FactorsAbstract Background: Pneumonia is still a leading cause of death among children in developing
countries.
The aim of the study is to identify some risk factors for poor pneumonia outcome. The studied
factors were: male sex, thrombocytosis, thrombocytopaenia, leucocytosis, leucopaenia and anae-
mia.
Patients and methods: A prospective cross sectional study included 242 children with community
acquired pneumonia (CAP) who were attending a tertiary care hospital. Work for the study started
at October 2012 and ended at August 2014. Medical history, physical examination, complete blood
count (CBC) and C-reactive protein were done for all patients.
Results: 27.3% of the patients developed pulmonary complications, 17.4% acquired sepsis while
death occurred in 3.7% of cases. Multinomial logistic regression was used to detect the independent
effect of each studied factor. Thrombocytosis, anaemia and age 62 years were associated with the
development of pulmonary complications. Thrombocytopaenia and leucopaenia were associated
with the fatal course of the disease. Male sex was a protective factor against pulmonary complica-
tions; however it was a risk factor for acquiring sepsis. Leucocytosis did not affect the prognosis of
CAP.
Conclusion: Sex of the patient and data from complete blood count are very useful for the pre-
diction of pneumonia outcome. Anaemia, thrombocytosis, thrombocytopaenia, and leucopaenia
are considered as predictors of bad prognosis. Females are more vulnerable to pulmonary
complications while maleness is associated with sepsis and determination of these indicators high-
lights suspicion of pneumonia prognosis and allows application of early appropriate interventions.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. All rights reserved.Introduction
Although there is an overall reduction in pneumonia mortal-
ity, it is still a leading cause of death among children espe-
cially in developing countries. In Africa, pneumonia related
deaths account for 14% of total deaths in children (17% ifd.
170 Z.TH. Atwaincluding the neonatal pneumonia cases) [1]. Sepsis and pul-
monary complications of pneumonia as pleural effusion,
empyema, lung abscess and multilobar inﬁltrates are associ-
ated with longer hospital stay and shock [2]. Respiratory fail-
ure, sepsis and cardiac complication are considered the most
important direct causes of death among patients with pneu-
monia [3,4]. Risk factors for acquiring pneumonia were
clearly detected by previous studies [5,6]. However, there are
lack of studies that investigate risk factors and predictors
for poor pneumonia outcome in children. The interaction
between gender and CAP is intermingled, no role of gender
was found in some studies [7], while males are more prone
to be hospitalized due to CAP than females in others [8]. It
has been evidenced that there is interaction between platelets
and bacterial infection. During bacterial infection, platelets
play a role in host defence [9]. The white blood count has
an important role in predicting the invasive bacterial infection
[10]. Anaemia is associated with acute bacterial infection;
there is inverse relationship between total leucocytic count
and haemoglobin level [11]. The hypothesis of this study is
that gender and ﬁndings of complete blood count at the time
of diagnosis of community acquired pneumonia (CAP) can
affect outcome and can be considered as risk factors for poor
prognosis of the disease. The objective is to determine risk
factors present on the moment of admission to hospital that
may guide clinicians recognizing this case as one with a poten-
tial bad outcome. The studied risk factors were male sex,
anaemia, leucopaenia, leucocytosis, thrombocytosis and
thrombocytopaenia. These factors can be easily elicited dur-
ing routine initial history and laboratory investigation. Initial
recognition and identiﬁcation of these predictors allow early
appropriate intervention which can help improving pneumo-
nia outcome.Methods
Study design and methods
A prospective cross-sectional study was conducted in a tertiary
health centre. The study enrolled 242 patients, 135 males and
107 females who were diagnosed as CAP. Work for the study
started at October 2012 and ended at August 2014. Diagnosis,
hospitalization and management were according to British
Thoracic Society guidelines for the management of community
acquired pneumonia in children: update 2011 [12]. The proto-
col for the research project has been approved by the regional
Ethics Committee. All experiments were carried out in compli-
ance with the relevant laws and guidelines in accordance with
the ethical standards of the declaration of Helsinki. Informed
consent was obtained from the parents after approval of the
experimental protocol by a local hums man ethics committee
(Revised January 2008).
Participants
Children aged from 1 month to 12 years who diagnosed as
CAP were included in the study. The diagnosis was based on
clinical (tachypnea, chest indrawing, nasal ﬂaring, crackles
and bronchial breathing) and radiological (chest inﬁltrates)
evaluations. [12].Exclusion criteria
Children aged less than 1 month.
Patients with associated other comorbidity (cardiac, renal,
hepatic or haematological diseases, immunodeﬁciency dis-
eases, chronic chest diseases, chronic inﬂammatory diseases,
and neurological diseases either upper or lower motor neuron
diseases).
Procedure
On arrival the following interventions were done for the
patients:
1. Complete medical history and physical examination.
2. Complete blood count (CBC), C reactive protein
(CRP).
3. Anteroposterior and lateral chest X rays.
The following data were recorded: sex and age of the
patient, platelet count (normal, high or low according to refer-
ence range for sex and age), total leucocyte count (normal,
high or low according to reference range for sex and age), hae-
moglobin level (normal or low according to reference range for
sex and age). The reference standard was estimated by an elec-
tronic cell counter. We used the hospital information system to
retrieve the test results of all study patients. Sputum culture
was not universally done, but it was done on failure of clinical
or radiological improvement after empirical treatment – Pres-
ence of severe disease at the time of pneumonia presentation
which is detected by the presence of at least one of the follow-
ing ﬁndings, ﬂaring of the nostrils, respiratory failure, cyano-
sis, torpor/coma, irritability, sepsis or shock [12].
After diagnosis of pneumonia, patients received appropriate
treatment which is recorded. Continuous observation and fol-
low upwere done for all patients with special emphasis on symp-
toms, signs, laboratory ﬁnding and radiological ﬁnding of sepsis
and pulmonary complications. Diagnosis and management of
empyema were according to British guidelines for the manage-
ment of pleural infection in children [13]. Lung abscess was sus-
pected by physical examination and X ray and conﬁrmed by
computerized tomography [14]. Sepsis was diagnosed according
to the criteria of International Consensus Deﬁnitions for paedi-
atric sepsis (core temperature of >38.5 C or <36 C, tachyp-
nea >2SD for age, tachycardia >2SD for age with the
absence of external stimulus plus evidence of infection). [15]
Variables
We studied the effect of sex, abnormal thrombocyte count,
abnormal leucocyte count and anaemia on pneumonia out-
come which was represented by the following parameters,
development of pulmonary complications, sepsis and death.
Statistical analysis
Collected data were computerized and analysed using the
Statistical Package for Social Science (SPSS) version 20.
Descriptive statistics were used to describe variables; percent-
age and proportion for qualitative variables. Quantitative
Table 1 Characteristics of studied patients.
N %
Age 62 years 182 75.2
2–6 years 44 18.2
P6 years 16 6.6
Sex Male 135 55.8
Female 107 44.2
HB level Normal 125 51.7
Anaemic 117 48.3
Leucocyte count Normal 77 31.8
Leucocytosis 149 61.6
Leucopaenia 16 6.6
Platelets count Normal 183 75.6
Thrombocytosis 46 19
Thrombocytopaenia 13 5.4
Sputum culture results Negative 2 0.8
Pneumococci 9 3.7
Staph. aureus 25 10.3
GBS 18 7.4
E. coli 2 0.8
Pseudomonas 5 2.1
Severe disease at the onset 84 34.7
Treatment prescribed Oral antibiotic, (amoxicillin) 80 33.1
Vial antibiotics 162 66.9
Pulmonary complications Absence 176 72.7
Presence 66 27.3
Sepsis Absence 200 82.6
Presence 42 17.4
Hospitalization period 62 weeks 161 66.5
>2 weeks 81 33.5
Death 30 day mortality 9 3.7
E. coli, Escherichia coli; GBS, group B streptococcus; N, number;
%, percentage; Staph. aureus, Staphylococcus aureus.
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level, minimum level and standard deviation. Multinomial
logistic regression analysis was done to detect independent risk
factors and to distinguish the separate effect of male sex, throm-
bocytosis, thrombocytopaenia, leucocytosis, leucopaenia and
anaemia. The variables of interest were death, occurrence of
sepsis and development of pulmonary complications. Stepwise
forward procedure was done where each variable was tested
separately against all the mentioned factors. Results were
expressed as odds ratio (OR) and 95% conﬁdence interval
(CI). Categorical variables were expressed as absence or pres-
ence. P-values with signiﬁcance of less than 0.05 were consid-
ered statistically signiﬁcant.
Results
The study enrols 242 children with CAP, 135 males and 107
females. Mean age is 16.99 months (range from 1.5
to140 months). Mean haemoglobin level (Hb) is 10.56 g/dl
(range from 6 to16 g/dl). Mean leucocyte count is 133,869/
cmm (range from 2000 to 20,000). Mean of platelets count is
327,990/cmm (range from 80,000 to 1,100,000/cmm).
75.2% of patients are younger than 2 years. Anaemia is
found in 48.3% of patients. 61.6% of patients were presented
with leucocytosis while 6.6% were presented with leucopaenia.
19% of patients had thrombocytosis and 5.4% had thrombo-
cytopaenia. 27.3% of patients developed pulmonary complica-
tions and 17.4% acquired sepsis. Death occurred in 3.7% of
patients (Table 1).
By logistic regression analysis to detect independent factors
for poor outcome, thrombocytosis (P, 0.000, OR 1. 56 CI,
.225–2.390), anaemia (P, 0.001, OR, 1.560, CI, 1.234–2.132)
and younger age (P, 0.000, OR, 2.590, CI, 2.222–3.054) are
associated with risk of pulmonary complications while male
sex was a protective factor (P, 0.042, OR, 1.058, CI,
1.368 to 1.107). Acquiring sepsis is associated with leuco-
paenia (P, 0.001, OR, 1.931, CI, 1.431–3.215), thrombocyto-
paenia (P, 0.019, OR, 1.28, CI, 1.002–1.503) and male sex
(P, 0.002, OR, 3.193, CI, 2.215–3.921). Leucocytosis is not
associated with poor pneumonia outcome (Table 2).
Death is associated with leucopaenia (P, 0.01, OR, 2.119,
CI, 1.322–3.102), thrombocytopaenia (P, 0.038, OR, 1.922,
CI, 1.531–3.43) and the presence of severe disease at the time
of diagnosis (P, 0.000, OR, 1.840, CI, 1.256–2.982) (Table 3).
Discussion
We reported the association of some factors with poor pneu-
monia outcome. These factors were male sex, abnormal throm-
bocyte count, abnormal leucocyte count and the presence of
anaemia. Development of pulmonary complications as (empy-
ema and lung abscess), acquiring sepsis and death were consid-
ered as indications of poor pneumonia outcomes.
In this study thrombocytosis was considered as a risk factor
for the development of pulmonary complication in pneumonic
patients. Incorporation of thrombocytes in the inﬂammatory
reaction as a part of defence mechanism [9] may explain
thrombocytosis in these cases. Thrombopoietin was considered
as an acute phase protein which is elevated in various inﬂam-
matory diseases, however it could not explain the cause of
thrombocytosis in these cases [16]. In agreement with ourresults a study by Prina et al. [17] considered thrombocytosis
as a strong indicator for occurrence of respiratory complica-
tion of pneumonia. In contrast, thrombocytosis was not con-
sidered as an indicator for occurrence of empyema or pleural
effusion in children with CAP in a study by Wolach et al.
[18]. In this article, pneumonic patients presented with throm-
bocytopaenia had increased risk of acquiring sepsis and
increased risk of mortality; however thrombocytopaenia was
not an indicator for the occurrence of pulmonary complication
among these patients. This is in agreement with Prina et al. [17]
who found that thrombocytopaenia in CAP patients was
strongly associated with severe sepsis (P= 0.001). Mirsaeidi
et al. [19] considered both thrombocytosis and thrombocyto-
paenia as predictors of death in CAP patients. Thrombocyto-
paenia was considered as a predictor of poor prognosis and a
higher rate of death in patients admitted at the intensive care
unit due to variable aetiologies (P< 0.0001, OR, 6.0, CI,
3.0–12.0) [20].
In the present study leucopaenia was considered as a pre-
dictor of a fatal course of pneumonia Presence of leucopaenia
at the time of pneumonia presentation was associated with sep-
sis (P, 0.001, OR, 1.931, CI, 1.431–3.215) and mortality (P,
0.01, OR, 2.119, CI, 1.322–3.102) .Impaired immune response
among these patients might be the cause of overwhelming sep-
sis and death. This is in agreement with a study that included
Table 2 Logistic regression to detect independent predictors for pulmonary complications and sepsis in children with pneumonia.
Pulmonary complications Sepsis
P-value Odd-ratio (95% conﬁdence
interval for odd)
P-value Odd-ratio (95% conﬁdence
interval for odd)
Age <2 years 0.000 2.590
(2.222, 3.054)
0.249 1.915
(0.634, 5.781)
Age from 2 to 6 years 0.38 0.637
(0.534, 1.346)
0.571 3.241
(1.498, 6.321)
Male sex 0.042 1.058
(1.368, 1.107)
0.002 3.193
(2.215, 3.921)
CRP (C-reactive protein) 0.521 1.198
(1.107, 1.368)
0.812 0.026
(0.213, 1.021)
Anaemia 0.001 1.560
(1.234, 2.132)
0.219 0.976
(0.534, 1.925)
Thrombocytosis 0.000 1. 56
(1.225, 2.390)
0.09 0.624
(0.246, 1.070)
Thrombocytopaenia 0.894 0.643
(0.482, 0.877)
0.019 1.280
(1.002, 1.503)
Leucocytosis 0.988 0.820
(0.623, 1.433)
0.745 1.153
(0.945, 1.844)
Leucopaenia 0.299 0.751
(0.563, 1.562)
0.001 1.931
(1.431, 3.215)
Starting treatment with oral amoxicillin 0.673 0.732
(0.086, 1.546)
0.110 0.156
(0.023, 0.214)
Table 3 Logistic regression to detect independent predictors for mortality in children with pneumonia.
P-value Odd-ratio 95% Conﬁdence interval for odd
Age <2 years 0.770 1.299 0.278, 5.644
Age from 2 to 6 years 0.679 1.345 0.534, 6.346
Male sex 0.231 0.098 0.420, 0.692
CRP (C-reactive protein) 0.840 1.456 1.013, 1.833
Anaemia 0.553 0.799 0.288, 1.045
Thrombocytosis 0.181 1.102 1.033, 1.569
Thrombocytopaenia 0.038 1.922 1.531, 3.431
Leucocytosis 0.787 1.128 0.833, 2.567
Leucopaenia 0.010 2.119 1.322, 3.102
Starting treatment with oral amoxicillin 0.620 1.040 0.330, 5.120
Severe pneumonia at presentation 0.000 1.840 1.256, 2.982
172 Z.TH. Atwapatients with staphylococcal pneumonia where leucopaenia
was strongly associated with poor outcome, however predic-
tors of leucopaenia varied from those of mortality [21]. Leuco-
paenia was also a risk factor of death in patients admitted to
the intensive care unit [22].In contrast to the indicative effect
of leucopaenia on the outcome of pneumonia, leucocytosis in
our study was not indicative of mortality (P= 0.787) or poor
outcome of pneumonia. In concordance to these ﬁndings, a
study by Bonadio where leucocytosis and high fever were not
associated with bacteraemia in pneumonic children older than
four months [23].
Anaemia was surprisingly common in patients with CAP
(48.3% of cases); this highlights a question about anaemia as
a predisposing cause of CAP. The answer of this question
may need further studies. Anaemia was associated with the
occurrence of pulmonary complication among children with
CAP (P= 0.001, OR, 1.560, CI, 1.234–2.132). However anae-
mia was not a predictive risk factor for acquiring sepsis or for
death among these patients. In a study among children with
pneumonia that was accompanied by anaemia at high altitude,anaemia was a predictor for worse prognosis and unrespon-
siveness to treatment [24]. In another study about the effect
of air pollution and anaemia on the rate of pneumonia hospi-
talization, anaemia in adjunctive with air pollution was found
to increase the rate of hospitalization while air pollution in
non-anaemic patients did not affect the rate of pneumonia hos-
pitalizations [25]. Earley et al. revealed that application of
anaemia management programme in ICU reduced the compli-
cation rate of ventilator acquired pneumonia [26].
As regards sex difference, although it was evidenced that
incidence of pneumonia in males is higher than that in females
[27]; yet the effect of sex on pneumonia outcome is not clear. In
our study, it was thestriking protective effect of male sex
against development of pulmonary complication in children
with pneumonia (P, 0.042, OR, 1.058, CI, 1.368 to
1.107). Sex differences in the local innate defence of the lung
as a phagocytic effect of alveolar macrophage and the effect of
sex hormones on phagocytic cells of the lung may explain these
results. These differences were evidenced in mice where males
were more susceptible to pneumonia than females however
Predicting pneumonia outcome in children 173after acquiring infection, in the presence of ozone exposure
females were more affected than males [28]. Further studies
in this topic in humans are recommended to better explain
the disparity of alveolar macrophage function among both
sexes. However, in this study male sex was a risk factor for
the development of sepsis in pneumonic children (P, 0.002,
OR, 3.193, CI, 2.215–3.921). Gender difference in cellular
immunity and immunomodulation of cytokines may be the
cause of variation in the rate of acquiring sepsis [29]. In this
issue male sex was not considered as a risk factor of mortality
among children with pneumonia (P, .23, OR, .098, CI,
0.420–0.692). This is in contrast to most other studies that
considered male sex as a risk factor for mortality among pneu-
monic children [30].
Conclusion
From the results of this investigation we can conclude that, in
children with CAP thrombocytosis and anaemia at the time of
presentation of the disease are considered as predictors for
development of pulmonary complication while thrombocyto-
paenia and leucopaenia are risk factors for acquiring sepsis
and for fatal outcome. Males with CAP are less vulnerable
to develop pulmonary complications while more vulnerable
to acquire sepsis. Leucocytosis is not indicative of poor CAP
outcome. We can consider these markers to expect the progno-
sis of CAP in children and so special care and early appropri-
ate intervention can be done to avoid the disease complication.
The great importance to the role of biomarkers in the diagnos-
tic and prognostic purposes drives us to recommend more
researches to explore the prognostic role of other biomarkers
as procalcitonin and lactate and results in blood gases.
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